Title |
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial
|
---|---|
Published in |
Reproductive Health, January 2015
|
DOI | 10.1186/1742-4755-12-5 |
Pubmed ID | |
Authors |
Michael Nambozi, Modest Mulenga, Tinto Halidou, Harry Tagbor, Victor Mwapasa, Linda Kalilani Phiri, Gertrude Kalanda, Innocent Valea, Maminata Traore, David Mwakazanga, Yves Claeys, Céline Schurmans, Maaike De Crop, Joris Menten, Raffaella Ravinetto, Kamala Thriemer, Jean-Pierre Van geertruyden, Theonest Mutabingwa, Umberto D’Alessandro, Pregact Group |
Abstract |
Asymptomatic and symptomatic malaria during pregnancy has consequences for both mother and her offspring. Unfortunately, there is insufficient information on the safety and efficacy of most antimalarials in pregnancy. Indeed, clinical trials assessing antimalarial treatments systematically exclude pregnancy for fear of teratogenicity and embryotoxicity. The little available information originates from South East Asia while in sub-Saharan Africa such information is still limited and needs to be provided. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Burkina Faso | 2 | <1% |
Indonesia | 1 | <1% |
United Kingdom | 1 | <1% |
Ethiopia | 1 | <1% |
Unknown | 213 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 37 | 17% |
Researcher | 30 | 14% |
Student > Ph. D. Student | 24 | 11% |
Student > Bachelor | 14 | 6% |
Student > Postgraduate | 11 | 5% |
Other | 41 | 19% |
Unknown | 61 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 61 | 28% |
Nursing and Health Professions | 19 | 9% |
Agricultural and Biological Sciences | 16 | 7% |
Social Sciences | 15 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
Other | 31 | 14% |
Unknown | 67 | 31% |